ArticlePloS one2025
Study of biological safety of camel milk after treatment with different antibiotics.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antimicrobial Use in Dromedary Camels: Off-Label Practices, Welfare Implications, and Antimicrobial Resistance Within a One Health Framework-A Narrative Review.Veterinary sciences · 2026Review
- Camel-Associated Antimicrobial Resistance: An Overlooked One Health Interface.Veterinary sciences · 2026Review
- Depletion of Amoxicillin and Its Major Metabolites in Anatolian Water Buffalo Milk After Intramuscular Administration.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of antibiotics in camels is generally based on the doses applied to cattle, despite the known differences in plasma pharmacokinetics between camel and cattle. The demand for camel milk increased due to the belief that traditional camel farming practices produce safe milk with health benefits. For assessing the importance of antibiotic residues in camel milk and to propose a convenient withdrawal period, a trial was conducted on 10 lactating camels (7-12 years old; 450 kg life weight (LW), 7-8 liter of milk production per day) at mid-lactation receiving an injection of 40 mL of Pen-strep® (benzylpenicillin-procaine 200,000 IU/1 ml and dihydrostreptomycin sulfate 200 mg/1 ml) and Nitox® (oxytetracycline dihydrate 200 mg/1 ml). The antibiotic residues were measured in the milk 30 min after injection then on day 1, 2, 3, 7, 9, 14, 19, 24 and 56 by using HPLC-MS/MS. Results showed that penicillin's mean residual concentration (0.3 ± 0.013 mg/kg) remained 7.5 times above the maximum residue limit (MRL) even on 56th day. In contrast, streptomycin fell below the MRL within 30 minutes and averaged 1 µg/kg by day 56. Oxytetracycline levels exceeded the MRL (0.1 mg/kg) until day 14 but dropped to a safe level of 0.018 ± 0.01 mg/kg by day 24. In conclusion, the decline in streptomycin concentration post-injection appeared rapid and efficient, the elimination of penicillin and tetracycline was slow. These preliminary results lead to considering the necessity to adapt the waiting time to the dairy camel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.